In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia
用户yq6YsVZ7xRog
1个月前
73
10
已完结
1. 系统已在2025-08-13 17:21:26对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1007/s11095-022-03267-1
文献链接: https://link.springer.com/10.1007/s11095-022-03267-1
其他信息:
出版社: Springer Science and Business Media LLC
作者: Guangqing Xiao; Yu-Luan Chen; Nina Dedic; Linghong Xie; Kenneth S. Koblan; Gerald R. Galluppi
全文下载地址: https://link.springer.com/content/pdf/10.1007/s11095-022-03267-1.pdf
